No opioids? new anesthesia method tested for gallbladder surgery
NCT ID NCT07306910
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a combination of lidocaine, dexmedetomidine, and magnesium instead of opioids can control pain and reduce nausea after gallbladder removal. 110 adults having elective laparoscopic cholecystectomy will be randomly assigned to opioid-free or standard opioid anesthesia. The main goal is to see if pain scores are lower with the opioid-free approach.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
opioid-free anesthesia (lidocaine, dexmedetomidine, magnesium)
What this could lead to
If it works, this could offer a safer way to manage pain during gallbladder surgery without using opioids.
What could go wrong
This is a small, early-stage study that hasn't started yet. The approach may not control pain as well as standard care, and side effects from the alternative drugs are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••